Acadian Asset Management’s Outset Medical OM Stock Holding History

Acadian Asset Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$149K	Sell	35,050 -4,705	-12%	-$20.6K	﹤0.01%	1683
2026 Q1	$149K	Sell	39,755 -87,513	-69%	-$359K	﹤0.01%	1660
2025 Q4	$468K	Buy	127,268 +27,305	+27%	+$234K	﹤0.01%	1322
2025 Q3	$1.41M	Buy	99,963 +75,622	+311%	+$1.18M	﹤0.01%	972
2025 Q2	$464K	Sell	24,341 -64,958	-73%	-$1.01M	﹤0.01%	1155
2025 Q1	$985K	Buy	89,299 +22,200	+33%	+$265K	﹤0.01%	940
2024 Q4	$1.11M	Sell	67,099 -19,776	-23%	-$247K	﹤0.01%	907
2024 Q3	$881K	Buy	86,875 +32,237	+59%	+$959K	﹤0.01%	947
2024 Q2	$3.15M	Buy	54,638 +2,689	+5%	+$132K	0.01%	633
2024 Q1	$1.73M	Buy	51,949 +40,881	+369%	+$2.07M	0.01%	694
2023 Q4	$896K	Buy	+11,068	New	+$901K	﹤0.01%	892

Other funds holding OM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Acadian Asset Management's OM Position: Q2 2026 in Review

Acadian Asset Management reduced its Outset Medical (OM) stake by 12% in Q2 2026, selling an estimated $20.6K and leaving 35,050 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #1683.

Acadian Asset Management first reported a position in OM in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.15M in Q2 2024. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

Acadian Asset Management held 35,050 shares of Outset Medical worth $149K as of Q2 2026.
Acadian Asset Management sold 4,705 Outset Medical shares in Q2 2026, an estimated $20.6K.
Outset Medical made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1683 holding.
Acadian Asset Management first reported a position in Outset Medical in Q4 2023 and has held it in 11 quarters since.
Acadian Asset Management's Outset Medical position peaked at $3.15M in Q2 2024.
93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.